text
stringlengths
81
4.38k
<s>Trial Id: Breast Cancer Index (BCI) Registry Recruitment Status: Active, not recruiting Trail description: The purpose of the Breast Cancer Index (BCI) Registry study is to conduct a large scale, population-based prospective registry to evaluate long-term clinical outcome, clinical impact, medication adherence and q...
<s>[INST] Provide inclusion criteria for trial id: NCT04875351 [/INST] Early stage (I, II or III) female breast cancer patients, who have completed 4-7 years of primary adjuvant endocrine therapy Patient was diagnosed with invasive breast carcinoma (ductal, lobular, or mixed ductal/lobular). The primary tumor was horm...
<s>[INST] Provide exclusion criteria for trial id: NCT04875351 [/INST] Patient has distant metastatic disease (M1). Patient was diagnosed with metaplastic breast cancer, carcinosarcoma, sarcoma, neuroendocrine carcinoma, adenoid cystic carcinoma, or phyllodes tumor. </s>
<s>[INST] Provide description for trial id: NCT04875351 [/INST] The purpose of the Breast Cancer Index (BCI) Registry study is to conduct a large scale, population-based prospective registry to evaluate long-term clinical outcome, clinical impact, medication adherence and quality of life in hormone receptor positive (...
<s>[INST] Provide title for trial id: NCT04875351 [/INST] Breast Cancer Index (BCI) Registry </s>
<s>[INST] Provide the recruitment status for trial id: NCT04875351 [/INST] Active, not recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT04875351 [/INST] Breast Cancer </s>
<s>Trial Id: Breast Cancer Risk Assessment in Women Aged 40-49 Recruitment Status: Completed Trail description: In a randomized controlled trial, the investigators will test the effect of a novel strategy for breast cancer risk assessment and risk-based management of women in their 40s seen in primary care. The investi...
<s>[INST] Provide inclusion criteria for trial id: NCT03180086 [/INST] women aged 40-49 years read and speak English scheduled for a routine visit or physical examination with a non-resident PCP in the next 4-12 weeks at HealthCare Associates (HCA, BIDMC's outpatient primary care practice). </s>
<s>[INST] Provide exclusion criteria for trial id: NCT03180086 [/INST] women scheduled for acute care women who had or will have a mammogram within 6 months of their PCP visit women with a history of breast cancer or a BRCA mutation women already receiving screening breast MRIs women who have been referred to genetic ...
<s>[INST] Provide description for trial id: NCT03180086 [/INST] In a randomized controlled trial, the investigators will test the effect of a novel strategy for breast cancer risk assessment and risk-based management of women in their 40s seen in primary care. The investigators anticipate that this approach will lead ...
<s>[INST] Provide title for trial id: NCT03180086 [/INST] Breast Cancer Risk Assessment in Women Aged 40-49 </s>
<s>[INST] Provide the recruitment status for trial id: NCT03180086 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT03180086 [/INST] Breast Cancer </s>
<s>Trial Id: Diagnosis Value of SEMA4C in Breast Cancer Recruitment Status: Not yet recruiting Trail description: Breast cancer remains the most common cancer in women worldwide. Early diagnosis can greatly improve the prognosis. To date, imaging examination is still the most important diagnostic and grading tool for b...
<s>[INST] Provide inclusion criteria for trial id: NCT03662633 [/INST] Receiving no treatment before diagnosis Establishing Diagnosis according to biopsy or surgery </s>
<s>[INST] Provide exclusion criteria for trial id: NCT03662633 [/INST] Patients who are not mentally capable of giving written informed consent Clinical data missing Serum samples doesn't qualified Patients with a diagnosis of other severe acute or chronic medical conditions that may interfere with the interpretation ...
<s>[INST] Provide description for trial id: NCT03662633 [/INST] Breast cancer remains the most common cancer in women worldwide. Early diagnosis can greatly improve the prognosis. To date, imaging examination is still the most important diagnostic and grading tool for breast cancer. Semaphorin4C (SEMA4C) has previousl...
<s>[INST] Provide title for trial id: NCT03662633 [/INST] Diagnosis Value of SEMA4C in Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT03662633 [/INST] Not yet recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT03662633 [/INST] Breast Neoplasm Female </s>
<s>Trial Id: A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China Recruitment Status: Unknown status Trail description: The purpose of the study is to study the epidemic features and diagnosis of female breast cancer, especially the diagnosis and treatment of breast cancer.The dise...
<s>[INST] Provide inclusion criteria for trial id: NCT02493569 [/INST] Female patients; The hospitalized patients who are confirmed of the primary breast cancer histologically; The date of the inpatients are within the month we chosen; Patients who are within the month we chosen have been received or under receiving t...
<s>[INST] Provide exclusion criteria for trial id: NCT02493569 [/INST] Male breast cancer patients; Patients with breast cancer who are not under the chosen time; Non hospitalized patients. </s>
<s>[INST] Provide description for trial id: NCT02493569 [/INST] The purpose of the study is to study the epidemic features and diagnosis of female breast cancer, especially the diagnosis and treatment of breast cancer.The disease-free survival (DFS) and the total survival time(OS) of the breast cancer patients will al...
<s>[INST] Provide title for trial id: NCT02493569 [/INST] A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China </s>
<s>[INST] Provide the recruitment status for trial id: NCT02493569 [/INST] Unknown status </s>
<s>[INST] Provide the medical condition for trial id: NCT02493569 [/INST] Breast Cancer </s>
<s>Trial Id: Role of Sorcin and Annexin A3 in Breast Cancer Patients Recruitment Status: Unknown status Trail description: Breast cancer (BC) is the most common female malignancy worldwide and the second leading cause of cancer death in women. One in eight women in the United States will develop the illness in their li...
<s>[INST] Provide inclusion criteria for trial id: NCT03598660 [/INST] breast cancer patients before surgery who are admitted to the South Egypt Cancer Institute, Surgery Department, Assiut University </s>
<s>[INST] Provide exclusion criteria for trial id: NCT03598660 [/INST] • Patients with malignancies elsewhere in the body. Patients with chronic cardiac diseases. Getting neoadjuvant chemotherapy. Renal disease. Neurodegenerative disease. </s>
<s>[INST] Provide description for trial id: NCT03598660 [/INST] Breast cancer (BC) is the most common female malignancy worldwide and the second leading cause of cancer death in women. One in eight women in the United States will develop the illness in their lifetimes. In Egypt, 37.7% of total cancer cases among women...
<s>[INST] Provide title for trial id: NCT03598660 [/INST] Role of Sorcin and Annexin A3 in Breast Cancer Patients </s>
<s>[INST] Provide the recruitment status for trial id: NCT03598660 [/INST] Unknown status </s>
<s>[INST] Provide the medical condition for trial id: NCT03598660 [/INST] Breast Cancer </s>
<s>Trial Id: Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases Recruitment Status: Recruiting Trail description: Bone metastases represent a frequent complication of some solid tumours, particularly prostate, breast and lung carcinomas. Bone metastases can cause pain and give rise to the so-called...
<s>[INST] Provide inclusion criteria for trial id: NCT04167605 [/INST] Adult women (≥ 18 years) candidates for excisional surgery and bone consolidation due to osteolytic bone metastases from breast cancer. Female Ability to understand the experimental study and willingness to sign the written consent </s>
<s>[INST] Provide exclusion criteria for trial id: NCT04167605 [/INST] - Retraction of written consent </s>
<s>[INST] Provide description for trial id: NCT04167605 [/INST] Bone metastases represent a frequent complication of some solid tumours, particularly prostate, breast and lung carcinomas. Bone metastases can cause pain and give rise to the so-called "Skeletal-related Events" (SRE) such as pathological fractures and ne...
<s>[INST] Provide title for trial id: NCT04167605 [/INST] Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases </s>
<s>[INST] Provide the recruitment status for trial id: NCT04167605 [/INST] Recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT04167605 [/INST] Breast Cancer Metastatic, Bone Metastases </s>
<s>Trial Id: Can MicroRNA's Predict Multicentricity in Breast Cancer? Recruitment Status: Completed Trail description: The aim of this study is to determine if microRNA's have role in predicting multicentricity in breast cancer. If a specific microRNA will be found to be related with multicentricity, it will help us to...
<s>[INST] Provide inclusion criteria for trial id: NCT04516330 [/INST] Having breast cancer Having no other malignancy Female patient </s>
<s>[INST] Provide exclusion criteria for trial id: NCT04516330 [/INST] Having other malignancy Under 18 years old Male patient </s>
<s>[INST] Provide description for trial id: NCT04516330 [/INST] The aim of this study is to determine if microRNA's have role in predicting multicentricity in breast cancer. If a specific microRNA will be found to be related with multicentricity, it will help us to make appropriate decisions on the treatment of patien...
<s>[INST] Provide title for trial id: NCT04516330 [/INST] Can MicroRNA's Predict Multicentricity in Breast Cancer? </s>
<s>[INST] Provide the recruitment status for trial id: NCT04516330 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT04516330 [/INST] Multicentric Breast Cancer </s>
<s>Trial Id: A Study to Identify Breast Cancer (IDBC) Recruitment Status: Unknown status Trail description: Detecting cancer as early as possible is key to achieving positive outcomes in response to diagnosis and treatment. The current project is aimed at validating a novel blood-based breast cancer identification test...
<s>[INST] Provide inclusion criteria for trial id: NCT04495244 [/INST] None </s>
<s>[INST] Provide exclusion criteria for trial id: NCT04495244 [/INST] None </s>
<s>[INST] Provide description for trial id: NCT04495244 [/INST] Detecting cancer as early as possible is key to achieving positive outcomes in response to diagnosis and treatment. The current project is aimed at validating a novel blood-based breast cancer identification test (Syantra DX Breast Cancer) that has been d...
<s>[INST] Provide title for trial id: NCT04495244 [/INST] A Study to Identify Breast Cancer (IDBC) </s>
<s>[INST] Provide the recruitment status for trial id: NCT04495244 [/INST] Unknown status </s>
<s>[INST] Provide the medical condition for trial id: NCT04495244 [/INST] Breast Cancer Female </s>
<s>Trial Id: The Effect of Breast Cancer Prevention Journey Program Recruitment Status: Not yet recruiting Trail description: The aim of this quasi-experimental study is to determine the effect of the "Breast Cancer Prevention Journey Program" on health beliefs about breast cancer in women over 40 years of age who have...
<s>[INST] Provide inclusion criteria for trial id: NCT06395896 [/INST] Being a woman between the ages of 40-69 Having never had a mammogram before </s>
<s>[INST] Provide exclusion criteria for trial id: NCT06395896 [/INST] Being diagnosed with breast cancer Having had a breast operation </s>
<s>[INST] Provide description for trial id: NCT06395896 [/INST] The aim of this quasi-experimental study is to determine the effect of the "Breast Cancer Prevention Journey Program" on health beliefs about breast cancer in women over 40 years of age who have never had a mammogram before. The research aims to answer th...
<s>[INST] Provide title for trial id: NCT06395896 [/INST] The Effect of Breast Cancer Prevention Journey Program </s>
<s>[INST] Provide the recruitment status for trial id: NCT06395896 [/INST] Not yet recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT06395896 [/INST] Breast Cancer Female </s>
<s>Trial Id: Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay Recruitment Status: Unknown status Trail description: Blood samples from a total of 200 women in two cohorts will be collected and analyzed by TM-B1 assay, which is based on TBIA (Total Biochemical Infrared Analysis)...
<s>[INST] Provide inclusion criteria for trial id: NCT03343691 [/INST] Screening Population: Subject signed the informed consent. Subject is aged 25 years and older. Subject is presenting for routine screening or diagnostic XRM and / or breast US. Breast Cancer Population Subject signed the informed consent form. S...
<s>[INST] Provide exclusion criteria for trial id: NCT03343691 [/INST] All Subjects: Subject has been diagnosed with any type of malignancy apart from breast cancer. Subject has been previously treated for breast cancer. Subject underwent any surgery within the previous year (apart from benign nevus removal). Subject...
<s>[INST] Provide description for trial id: NCT03343691 [/INST] Blood samples from a total of 200 women in two cohorts will be collected and analyzed by TM-B1 assay, which is based on TBIA (Total Biochemical Infrared Analysis) to confirm the presence of cancer. These two cohorts will yield 75 healthy women with no pat...
<s>[INST] Provide title for trial id: NCT03343691 [/INST] Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay </s>
<s>[INST] Provide the recruitment status for trial id: NCT03343691 [/INST] Unknown status </s>
<s>[INST] Provide the medical condition for trial id: NCT03343691 [/INST] Breast Cancer </s>
<s>Trial Id: FH-Risk 2.0: Updating Breast Cancer Risk Estimates Recruitment Status: Completed Trail description: In the UK women with a strong family history of breast cancer are eligible for breast cancer risk estimation via Family History Risk and Prevention Clinics (FHRPCs). Here breast cancer risk is calculated usi...
<s>[INST] Provide inclusion criteria for trial id: NCT05082740 [/INST] previously given informed consent to participate in the original FH-Risk study, have an up to date clear mammogram, aged between 25 and 60, have not developed breast cancer and, have the capacity to consent. </s>
<s>[INST] Provide exclusion criteria for trial id: NCT05082740 [/INST] women who have received a diagnosis of breast cancer, women who have not had a clear mammogram, women who took part in the original FH-Risk study but did not consent for their data to be used in future research and, women who lack the capacity to c...
<s>[INST] Provide description for trial id: NCT05082740 [/INST] In the UK women with a strong family history of breast cancer are eligible for breast cancer risk estimation via Family History Risk and Prevention Clinics (FHRPCs). Here breast cancer risk is calculated using popular risk prediction models like the Tyrer...
<s>[INST] Provide title for trial id: NCT05082740 [/INST] FH-Risk 2.0: Updating Breast Cancer Risk Estimates </s>
<s>[INST] Provide the recruitment status for trial id: NCT05082740 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT05082740 [/INST] Breast Cancer Risk </s>
<s>Trial Id: Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples Recruitment Status: Completed Trail description: Breast cancer is the most common cancer and cause of cancer- related deaths among women, accounting for 1.67 million (25.2%) new cases and 521,907 (14.7%) deaths worldwide...
<s>[INST] Provide inclusion criteria for trial id: NCT05570266 [/INST] For case group Had been diagnosed with primary breast cancer or tested positive for high penetrance genes (e.g. BRCA 1/2) Menarche age >12 years old Premenopausal For control group Premenopausal Menarche age >12 years old Asymptomatic Consented ...
<s>[INST] Provide exclusion criteria for trial id: NCT05570266 [/INST] For case group: First degree family history of breast or ovarian cancer For control group: Family history of breast or ovarian cancer First-degree relationship with the cases </s>
<s>[INST] Provide description for trial id: NCT05570266 [/INST] Breast cancer is the most common cancer and cause of cancer- related deaths among women, accounting for 1.67 million (25.2%) new cases and 521,907 (14.7%) deaths worldwide. The prevalence and survival rates of breast cancer differ per country. In Indonesi...
<s>[INST] Provide title for trial id: NCT05570266 [/INST] Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples </s>
<s>[INST] Provide the recruitment status for trial id: NCT05570266 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT05570266 [/INST] Breast Cancer </s>
<s>Trial Id: What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer? Recruitment Status: Recruiting Trail description: Italian, multicenter, study aimed at defining the best interval for screening women 45-49 and 70-74 years for Breast Cancer (BC). This research project includes (1) a controlled, p...
<s>[INST] Provide inclusion criteria for trial id: NCT04590560 [/INST] Women invited for their first or second mammography (45 or 46 y/o) presenting for screening; Willingness and ability to comply with scheduled visits; Written informed consent obtained prior to performing any protocol-related procedures. </s>
<s>[INST] Provide exclusion criteria for trial id: NCT04590560 [/INST] Pregnancy status; Personal history of prior breast carcinoma, either invasive or ductal carcinoma in situ (DCIS) diagnosis; Ascertained heredo-familial risk according to the standard family history used in screening programs; Participation in anoth...
<s>[INST] Provide description for trial id: NCT04590560 [/INST] Italian, multicenter, study aimed at defining the best interval for screening women 45-49 and 70-74 years for Breast Cancer (BC). This research project includes (1) a controlled, prospective randomized non-inferiority trial to determine the optimal screen...
<s>[INST] Provide title for trial id: NCT04590560 [/INST] What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer? </s>
<s>[INST] Provide the recruitment status for trial id: NCT04590560 [/INST] Recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT04590560 [/INST] Breast Cancer </s>
<s>Trial Id: Weight Loss and Breast Cancer Recruitment Status: Not yet recruiting Trail description: Obesity is an important risk factor for postmenopausal breast cancer. A large meta-analysis concluded that obesity is associated with a 20% to 40% increased risk for receptor-positive postmenopausal breast cancer. The I...
<s>[INST] Provide inclusion criteria for trial id: NCT05654571 [/INST] 40 years and older (age as of 2022, not the age of operation) LSG was applied in our clinic due to morbid obesity. Patients whose mamagrofi images are available in the hospital system </s>
<s>[INST] Provide exclusion criteria for trial id: NCT05654571 [/INST] Patients who underwent abdominal surgery again after LSG Patients whose mamagrophy image is not in the system Patients with suspicious findings as a result of mammography and who did not undergo additional imaging or biopsy Patients out of follow-u...
<s>[INST] Provide description for trial id: NCT05654571 [/INST] Obesity is an important risk factor for postmenopausal breast cancer. A large meta-analysis concluded that obesity is associated with a 20% to 40% increased risk for receptor-positive postmenopausal breast cancer. The International Agency for Research on ...
<s>[INST] Provide title for trial id: NCT05654571 [/INST] Weight Loss and Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT05654571 [/INST] Not yet recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT05654571 [/INST] Breast Cancer, Obesity, Morbid </s>
<s>Trial Id: Breast Cancer Prevention Education Recruitment Status: Completed Trail description: We will develop and evaluate a community-based approach for disseminating comparative effective reviews (CERs) about breast cancer prevention to African American women. The specific aims of our research, as shown below, wil...
<s>[INST] Provide inclusion criteria for trial id: NCT01299623 [/INST] African American women Ages 35-70 No personal history of cancer Resident of Philadelphia metropolitan area </s>